Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial. (opent nieuw venster)

Abdel-Aleem H, Alhusaini TK, Abdel-Aleem MA, Menoufy M, Gülmezoglu AM.

Bron‎: J Matern Fetal Neonatal Med 2013;26(17):1705-9.

Geïndexeerd‎: PubMed 23574458

https://www.ncbi.nlm.nih.gov/pubmed/23574458 (opent nieuw venster)

Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. (opent nieuw venster)

Gayet-Ageron A, Prieto-Merino D, Ker K, Shakur H, Ageron FX, Roberts I; Antifibrinolytic Trials Collaboration

Bron‎: Lancet 2018;391(10116):125-32.

Geïndexeerd‎: PubMed 29126600

DOI‎: 10.1016/S0140-6736(17)32455-8

https://www.ncbi.nlm.nih.gov/pubmed/29126600 (opent nieuw venster)

Can intravenous injection of tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study. (opent nieuw venster)

Gungorduk K, Asıcıoğlu O, Yıldırım G, Ark C, Tekirdağ Aİ, Besımoglu B.

Bron‎: Am J Perinatol 2013;30(5):407-13.

Geïndexeerd‎: PubMed 23023559

DOI‎: 10.1055/s-0032-1326986

https://www.ncbi.nlm.nih.gov/pubmed/23023559 (opent nieuw venster)

Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study. (opent nieuw venster)

Gungorduk K, Yıldırım G, Asıcıoğlu O, Gungorduk OC, Sudolmus S, Ark C.

Bron‎: Am J Perinatol 2011;28(3):233-40.

Geïndexeerd‎: PubMed 20979013

https://www.ncbi.nlm.nih.gov/pubmed/20979013 (opent nieuw venster)

Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. (opent nieuw venster)

Shakur S, Roberts I, Fawole B, Chaudhri R, El-Sheikh M, et al.; WOMAN Trial Collaborators

Bron‎: Lancet 2017;389(10084):2105-16.

Geïndexeerd‎: PubMed 28456509

DOI‎: 10.1016/S0140-6736(17)30638-4

https://www.ncbi.nlm.nih.gov/pubmed/28456509 (opent nieuw venster)

Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials. (opent nieuw venster)

Simonazzi G, Bisulli M, Saccone G, Moro E, Marshall A, Berghella V.

Bron‎: Acta Obstet Gynecol Scand 2016;95(1):28-37.

Geïndexeerd‎: PubMed 26698831

DOI‎: 10.1111/aogs.12798

https://www.ncbi.nlm.nih.gov/pubmed/26698831 (opent nieuw venster)

Randomized controlled trial of tranexamic acid among parturients at increased risk for postpartum hemorrhage undergoing cesarean delivery. (opent nieuw venster)

Sujata N, Tobin R, Kaur R, Aneja A, Khanna M, Hanjoora VM.

Bron‎: Int J Gynaecol Obstet 2016;133(3):312-5.

Geïndexeerd‎: PubMed 26952346

DOI‎: 10.1016/j.ijgo.2015.09.032

https://www.ncbi.nlm.nih.gov/pubmed/26952346 (opent nieuw venster)

Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004. (opent nieuw venster)

Alfirevic Z, Elbourne D, Pavord S, Bolte A, Van Geijn H, Mercier F, Ahonen J, Bremme K, Bødker B, Magnúsdóttir EM, Salvesen K, Prendiville W, Truesdale A, Clemens F, Piercy D, Gyte G.

Bron‎: Obstet Gynecol 2007;110(6):1270-8.

Geïndexeerd‎: PubMed 18055720

DOI‎: 10.1097/01.AOG.0000288515.48066.99

https://www.ncbi.nlm.nih.gov/pubmed/18055720 (opent nieuw venster)

The use of recombinant activated FVII in postpartum hemorrhage. (opent nieuw venster)

Franchini M, Franchi M, Bergamini V, Montagnana M, Salvagno GL, Targher G, Lippi G.

Bron‎: Clin Obstet Gynecol 2010;53(1):219-27.

Geïndexeerd‎: PubMed 20142658

DOI‎: 10.1097/GRF.0b013e3181cc4378

https://www.ncbi.nlm.nih.gov/pubmed/20142658 (opent nieuw venster)

Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study. (opent nieuw venster)

Huber AW, Raio L, Alberio L, Ghezzi F, Surbek DV.

Bron‎: J Perinat Med 2011;40(1):43-9.

Geïndexeerd‎: PubMed 22017328

DOI‎: 10.1515/JPM.2011.109

https://www.ncbi.nlm.nih.gov/pubmed/22017328 (opent nieuw venster)

Postpartum hemorrhage: when uterotonics and sutures fail. (opent nieuw venster)

James AH, McLintock C, Lockhart E.

Bron‎: Am J Hematol 2012;87 Suppl 1:S16-22.

Geïndexeerd‎: PubMed 22430921

DOI‎: 10.1002/ajh.23156

https://www.ncbi.nlm.nih.gov/pubmed/22430921 (opent nieuw venster)

Recombinant activated factor VII (rFVIIa/NovoSeven®) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in Japan. (opent nieuw venster)

Kobayashi T, Nakabayashi M, Yoshioka A, Maeda M, Ikenoue T.

Bron‎: Int J Hematol 2012;95(1):57-63.

Geïndexeerd‎: PubMed 22160834

DOI‎: 10.1007/s12185-011-0974-9

https://www.ncbi.nlm.nih.gov/pubmed/22160834 (opent nieuw venster)

Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial. (opent nieuw venster)

Lavigne-Lissalde G, Aya AG, Mercier FJ, Roger-Christoph S, Chauleur C, Morau E, Ducloy-Bouthors AS, Mignon A, Raucoules M, Bongain A, Boehlen F, de Moerloose P, Bouvet S, Fabbro-Peray P, Gris JC.

Bron‎: J Thromb Haemost 2015;13(4):520-9.

Geïndexeerd‎: PubMed 25594352

DOI‎: 10.1111/jth.12844

https://www.ncbi.nlm.nih.gov/pubmed/25594352 (opent nieuw venster)

Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy. (opent nieuw venster)

Lim Y, Loo CC, Chia V, Fun W.

Bron‎: Int J Gynaecol Obstet 2004;87(2):178-9.

Geïndexeerd‎: PubMed 15491576

DOI‎: 10.1016/j.ijgo.2004.08.007

https://www.ncbi.nlm.nih.gov/pubmed/15491576 (opent nieuw venster)

Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. (opent nieuw venster)

Moscardó F, Pérez F, de la Rubia J, Balerdi B, Lorenzo JI, Senent ML, Aznar I, Carceller S, Sanz MA.

Bron‎: Br J Haematol 2001;114(1):174-6.

Geïndexeerd‎: PubMed 11472364

https://www.ncbi.nlm.nih.gov/pubmed/11472364 (opent nieuw venster)

Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage. (opent nieuw venster)

Nohira T, Osakabe Y, Suda S, Takahashi C, Tanaka A, Ikeda K, Ikeda T, Okabe K.

Bron‎: J Obstet Gynaecol Res 2008;34(4 Pt 2):623-30.

Geïndexeerd‎: PubMed 18840167

https://www.ncbi.nlm.nih.gov/pubmed/18840167 (opent nieuw venster)

Recombinant factor VIIa as last-resort treatment of desperate haemorrhage. (opent nieuw venster)

Palmason R, Vidarsson B, Sigvaldason K, Ingimarsson JP, Gudbjartsson T, Sigurdsson GH, Onundarson PT.

Bron‎: Acta Anaesthesiol Scand 2012;56(5):636-44.

Geïndexeerd‎: PubMed 22489992

DOI‎: 10.1111/j.1399-6576.2012.02688.x

https://www.ncbi.nlm.nih.gov/pubmed/22489992 (opent nieuw venster)

Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation. (opent nieuw venster)

Pepas LP, Arif-Adib M, Kadir RA.

Bron‎: Obstet Gynecol 2006;108(3 Pt 2):757-61.

Geïndexeerd‎: PubMed 17018493

DOI‎: 10.1097/01.AOG.0000197064.44340.d4

https://www.ncbi.nlm.nih.gov/pubmed/17018493 (opent nieuw venster)

Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. (opent nieuw venster)

Phillips LE, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, Ogle R, Cameron PA; Australian and New Zealand Haemostasis Registry.

Bron‎: Anesth Analg 2009;109(6):1908-15.

Geïndexeerd‎: PubMed 19923520

DOI‎: 10.1213/ANE.0b013e3181c039e6

https://www.ncbi.nlm.nih.gov/pubmed/19923520 (opent nieuw venster)

Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism. (opent nieuw venster)

Prosper SC, Goudge CS, Lupo VR.

Bron‎: Obstet Gynecol 2007;109(2 Pt2):524-5.

Geïndexeerd‎: PubMed 17267882

DOI‎: 10.1097/01.AOG.0000235711.11817.8c

https://www.ncbi.nlm.nih.gov/pubmed/17267882 (opent nieuw venster)

The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage--an observational study. (opent nieuw venster)

Ahmed S, Harrity C, Johnson S, Varadkar S, McMorrow S, Fanning R, Flynn CM, O'Riordan JM, Byrne BM.

Bron‎: Transfus Med 2012;22(5):344-9.

Geïndexeerd‎: PubMed 22994449

https://www.ncbi.nlm.nih.gov/pubmed/22994449 (opent nieuw venster)

The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. (opent nieuw venster)

Bell SF, Rayment R, Collins PW, Collis RE.

Bron‎: Int J Obstet Anesth 2010;19(2):218-23.

Geïndexeerd‎: PubMed 20194010

DOI‎: 10.1016/j.ijoa.2009.08.004

https://www.ncbi.nlm.nih.gov/pubmed/20194010 (opent nieuw venster)

Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. (opent nieuw venster)

Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, Bouvier-Colle MH, Huissoud C.

Bron‎: Br J Anaesth 2012;108(6):984-9.

Geïndexeerd‎: PubMed 22490316

DOI‎: 10.1093/bja/aes096

https://www.ncbi.nlm.nih.gov/pubmed/22490316 (opent nieuw venster)

Association between fibrinogen levels and severity of postpartum hemorrhage in singleton vaginal deliveries at a Japanese perinatal center. (opent nieuw venster)

Shibata Y, Shigemi D, Ito M, Terada K, Nakanishi K, Kato M, Igarashi M, Suzuki S.

Bron‎: J Nippon Med Sch 2014;81(2):94-6.

Geïndexeerd‎: PubMed 24805095

https://www.ncbi.nlm.nih.gov/pubmed/24805095 (opent nieuw venster)

A systematic review: the use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy. (opent nieuw venster)

Trigg DE, Stergiotou I, Peitsidis P, Kadir RA.

Bron‎: Haemophilia 2012;18(1):25-33.

Geïndexeerd‎: PubMed 21624012

DOI‎: 10.1111/j.1365-2516.2011.02573.x

https://www.ncbi.nlm.nih.gov/pubmed/21624012 (opent nieuw venster)

Tisseel for management of traumatic postpartum haemorrhage. (opent nieuw venster)

Dhulkotia JS, Alazzam M, Galimberti A.

Bron‎: Arch Gynecol Obstet 2009;279(3):437-9.

Geïndexeerd‎: PubMed 18985368

DOI‎: 10.1007/s00404-008-0824-z

https://www.ncbi.nlm.nih.gov/pubmed/18985368 (opent nieuw venster)

Use of FloSeal haemostatic gel in massive obstetric haemorrhage: a case report. (opent nieuw venster)

Moriarty KT, Premila S, Bulmer PJ.

Bron‎: BJOG 2008;115(6):793-5.

Geïndexeerd‎: PubMed 18355369

DOI‎: 10.1111/j.1471-0528.2007.01654.x

https://www.ncbi.nlm.nih.gov/pubmed/18355369 (opent nieuw venster)

Topical application of recombinant activated factor VII during cesarean delivery for placenta previa. (opent nieuw venster)

Schjoldager BTBG, Mikkelsen E, Lykke MR, Præst J, Hvas AM, Heslet L, Secher NJ, Salvig JD, Uldbjerg N

Bron‎: Am J Obstet Gynecol 2017;216(6):608.e1-5.

Geïndexeerd‎: PubMed 28219621

DOI‎: 10.1016/j.ajog.2017.02.024

https://www.ncbi.nlm.nih.gov/pubmed/28219621 (opent nieuw venster)

Fibrin sealant for management of complicated obstetric lacerations. (opent nieuw venster)

Whiteside JL, Asif RB, Novello RJ.

Bron‎: Obstet Gynecol 2010;115(2 Pt 2):403-4.

Geïndexeerd‎: PubMed 20093858

DOI‎: 10.1097/AOG.0b013e3181bb1e28

https://www.ncbi.nlm.nih.gov/pubmed/20093858 (opent nieuw venster)

Role of thromboelastography versus coagulation screen as a safety predictor in pre-eclampsia/eclampsia patients undergoing lower-segment caesarean section in regional anaesthesia. (opent nieuw venster)

Ahmad A, Kohli M, Malik A, Kohli M, Bogra J, Abbas H, Gupta R, Kushwaha BB.

Bron‎: J Obstet Gynaecol India 2016;66(Suppl 1):340-6.

Geïndexeerd‎: PubMed 27651627

https://www.ncbi.nlm.nih.gov/pubmed/27651627 (opent nieuw venster)

Assessment of coagulation in the obstetric population using ROTEM® thromboelastometry. (opent nieuw venster)

Armstrong S, Fernando R, Ashpole K, Simons R, Columb M.

Bron‎: Int J Obstet Anesth 2011;20(4):293-8.

Geïndexeerd‎: PubMed 21835606

https://www.ncbi.nlm.nih.gov/pubmed/21835606 (opent nieuw venster)

Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. (opent nieuw venster)

de Lange NM, Lancé MD, de Groot R, Beckers EA, Henskens YM, Scheepers HC.

Bron‎: Obstet Gynecol Surv 2012;67(7):426-35.

Geïndexeerd‎: PubMed 22926249

DOI‎: 10.1097/OGX.0b013e3182605861

https://www.ncbi.nlm.nih.gov/pubmed/22926249 (opent nieuw venster)

Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both? (opent nieuw venster)

Karlsson O, Jeppsson A, Hellgren M.

Bron‎: Int J Obstet Anesth 2014;23(1):10-7.

Geïndexeerd‎: PubMed 24342222

https://www.ncbi.nlm.nih.gov/pubmed/24342222 (opent nieuw venster)

Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. (opent nieuw venster)

Levy JH, Welsby I, Goodnough LT.

Bron‎: Transfusion 2014;54(5):1389-405.

Geïndexeerd‎: PubMed 24117955

DOI‎: 10.1111/trf.12431

https://www.ncbi.nlm.nih.gov/pubmed/24117955 (opent nieuw venster)

Coagulopathy and placental abruption: changing management with ROTEM-guided fibrinogen concentrate therapy. (opent nieuw venster)

McNamara H, Mallaiah S, Barclay P, Chevannes C, Bhalla A.

Bron‎: Int J Obstet Anesth 2015;24(2):174-9.

Geïndexeerd‎: PubMed 25659517

https://www.ncbi.nlm.nih.gov/pubmed/25659517 (opent nieuw venster)

Haemostatic monitoring during postpartum haemorrhage and implications for management. (opent nieuw venster)

Solomon C, Collis RE, Collins PW.

Bron‎: Br J Anaesth 2012;109(6):851-63.

Geïndexeerd‎: PubMed 23075633

DOI‎: 10.1093/bja/aes361

https://www.ncbi.nlm.nih.gov/pubmed/23075633 (opent nieuw venster)